Targeted delivery of nano-therapeutics for major disorders of the central nervous system

H Gao, Z Pang, X Jiang - Pharmaceutical research, 2013 - Springer
Major central nervous system (CNS) disorders, including brain tumors, Alzheimer's disease,
Parkinson's disease, and stroke, are significant threats to human health. Although …

Strategies facilitating the permeation of nanoparticles through blood-brain barrier: An insight towards the development of brain-targeted drug delivery system

A Mishra, R Kumar, J Mishra, K Dutta, P Ahlawat… - Journal of Drug Delivery …, 2023 - Elsevier
The blood-brain barrier (BBB) is a membrane barrier considered one of the most crucial
protective architectures in the central nervous system (CNS). Its presence acts as a hurdle …

Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics

SD Hettiarachchi, Y Zhou, E Seven… - Journal of controlled …, 2019 - Elsevier
Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disorder
manifested by memory loss and cognitive impairment. Deposition of the amyloid β plaques …

Bioinspired theranostic coordination polymer nanoparticles for intranasal dopamine replacement in Parkinson's disease

J García-Pardo, F Novio, F Nador, I Cavaliere… - ACS …, 2021 - ACS Publications
Dopamine (DA) is one of the main neurotransmitters found in the central nervous system
and has a vital role in the function of dopaminergic (DArgic) neurons. A progressive loss of …

Ameliorating mitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated mitochondrial biogenesis to boost the therapy of Parkinson's …

Q Zheng, H Liu, H Zhang, Y Han, J Yuan… - Advanced …, 2023 - Wiley Online Library
Mitochondrial dysfunction of neurons is the core pathogenesis of incurable Parkinson's
disease (PD). It is crucial to ameliorate the mitochondrial dysfunction of neurons for boosting …

Polymeric nanoparticles-based brain delivery with improved therapeutic efficacy of ginkgolide B in Parkinson's disease

Y Zhao, S Xiong, P Liu, W Liu, Q Wang… - International journal …, 2020 - Taylor & Francis
Purpose Ginkgolide B (GB) is a terpene lactone derivative of Ginkgo biloba that is believed
to function in a neuroprotective manner ideal for treating Parkinson's disease (PD). Despite …

Development of engineered nanoparticles expediting diagnostic and therapeutic applications across blood–brain barrier

MN Sardoiwala, B Kaundal, SR Choudhury - Handbook of nanomaterials …, 2018 - Elsevier
Blood–brain barrier (BBB) is the natural protective tight junctions of epithelial cells that
separate blood vessels from cerebrospinal fluid for protection of brain from various toxic and …

Emerging nanotechnology for treatment of Alzheimer's and Parkinson's disease

A Li, J Tyson, S Patel, M Patel, S Katakam… - … in Bioengineering and …, 2021 - frontiersin.org
The prevalence of the two most common neurodegenerative diseases, Parkinson's disease
(PD) and Alzheimer's Disease (AD), are expected to rise alongside the progressive aging of …

Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease

S Tang, A Wang, X Yan, L Chu, X Yang, Y Song… - Drug Delivery, 2019 - Taylor & Francis
Efficient delivery of brain-targeted drugs is highly important for successful therapy in
Parkinson's disease (PD). This study was designed to formulate borneol and lactoferrin co …

Increased antiparkinson efficacy of the combined administration of VEGF-and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease

E Herran, C Requejo, JA Ruiz-Ortega… - International Journal …, 2014 - Taylor & Francis
Current research efforts are focused on the application of growth factors, such as glial cell
line-derived neurotrophic factor (GDNF) and vascular endothelial growth factor (VEGF), as …